Baidu
map

Prostate Cancer P D:良性前列腺增生中摘除术与切除术效果和安全性评估

2019-03-15 AlexYang MedSci原创

最近,有研究人员比较了前列腺经尿道摘除与切除术对治疗良性前列腺增生(BPH)的效果安全性情况。研究人员的元分析搜索的内容在2018年9月1日之前,所有包括的研究均为随机对照试验(RCTs)。研究人员根据国际前列腺症状评分(IPSS)、最大尿流率(Qmax)和生活质量(QoL)对效果进行了评价,并对围手术期资料及术后并发症也进行了评估。另外,研究人员还使用科克伦系统和GRADE系统对生活质量进行了评

最近,有研究人员比较了前列腺经尿道摘除与切除术对治疗良性前列腺增生(BPH)的效果安全性情况。

研究人员的元分析搜索的内容在2018年9月1日之前,所有包括的研究均为随机对照试验(RCTs)。研究人员根据国际前列腺症状评分(IPSS)、最大尿流率(Qmax)和生活质量(QoL)对效果进行了评价,并对围手术期资料及术后并发症也进行了评估。另外,研究人员还使用科克伦系统和GRADE系统对生活质量进行了评估。研究总共包括了26个RCTs,共3283名患者。研究发现,在术后第1、3和6个月时,摘除术和切除术在IPSS、Qmax和QoL中没有显著差异。在术后第12个月,摘除术组中的IPSS和Qmax要比切除术组显著更好。这些结果同时也表明了摘除术要比切除术在住院时间、血红蛋白丢失、血钠降低和输血率以及等级II和III并发症以及早期并发症方面更有优势。然而,切除术表现出了更好的手术时间。

最后,研究人员指出,与切除术比较,摘除术表现出了更高的治疗效果和术后安全性,更少的血液变化和严重的并发症。但是,在手术时间上并没有优势。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1877131, encodeId=e67d18e71315f, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sat Sep 07 21:26:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791570, encodeId=4e3d1e91570fb, content=<a href='/topic/show?id=b77f14e4541' target=_blank style='color:#2F92EE;'>#Prostate Ca#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14745, encryptionId=b77f14e4541, topicName=Prostate Ca)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Thu Nov 21 23:26:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364467, encodeId=9791136446e71, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Sun Mar 17 03:26:00 CST 2019, time=2019-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509694, encodeId=37f8150969477, content=<a href='/topic/show?id=c96f866535c' target=_blank style='color:#2F92EE;'>#良性前列腺增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86653, encryptionId=c96f866535c, topicName=良性前列腺增生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42f10130242, createdName=刘阔, createdTime=Sun Mar 17 03:26:00 CST 2019, time=2019-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602132, encodeId=947f1602132c5, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Sun Mar 17 03:26:00 CST 2019, time=2019-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046775, encodeId=92b11046e75c4, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Mar 15 15:26:00 CST 2019, time=2019-03-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1877131, encodeId=e67d18e71315f, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sat Sep 07 21:26:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791570, encodeId=4e3d1e91570fb, content=<a href='/topic/show?id=b77f14e4541' target=_blank style='color:#2F92EE;'>#Prostate Ca#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14745, encryptionId=b77f14e4541, topicName=Prostate Ca)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Thu Nov 21 23:26:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364467, encodeId=9791136446e71, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Sun Mar 17 03:26:00 CST 2019, time=2019-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509694, encodeId=37f8150969477, content=<a href='/topic/show?id=c96f866535c' target=_blank style='color:#2F92EE;'>#良性前列腺增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86653, encryptionId=c96f866535c, topicName=良性前列腺增生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42f10130242, createdName=刘阔, createdTime=Sun Mar 17 03:26:00 CST 2019, time=2019-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602132, encodeId=947f1602132c5, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Sun Mar 17 03:26:00 CST 2019, time=2019-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046775, encodeId=92b11046e75c4, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Mar 15 15:26:00 CST 2019, time=2019-03-15, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1877131, encodeId=e67d18e71315f, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sat Sep 07 21:26:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791570, encodeId=4e3d1e91570fb, content=<a href='/topic/show?id=b77f14e4541' target=_blank style='color:#2F92EE;'>#Prostate Ca#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14745, encryptionId=b77f14e4541, topicName=Prostate Ca)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Thu Nov 21 23:26:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364467, encodeId=9791136446e71, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Sun Mar 17 03:26:00 CST 2019, time=2019-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509694, encodeId=37f8150969477, content=<a href='/topic/show?id=c96f866535c' target=_blank style='color:#2F92EE;'>#良性前列腺增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86653, encryptionId=c96f866535c, topicName=良性前列腺增生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42f10130242, createdName=刘阔, createdTime=Sun Mar 17 03:26:00 CST 2019, time=2019-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602132, encodeId=947f1602132c5, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Sun Mar 17 03:26:00 CST 2019, time=2019-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046775, encodeId=92b11046e75c4, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Mar 15 15:26:00 CST 2019, time=2019-03-15, status=1, ipAttribution=)]
    2019-03-17 lsndxfj
  4. [GetPortalCommentsPageByObjectIdResponse(id=1877131, encodeId=e67d18e71315f, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sat Sep 07 21:26:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791570, encodeId=4e3d1e91570fb, content=<a href='/topic/show?id=b77f14e4541' target=_blank style='color:#2F92EE;'>#Prostate Ca#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14745, encryptionId=b77f14e4541, topicName=Prostate Ca)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Thu Nov 21 23:26:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364467, encodeId=9791136446e71, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Sun Mar 17 03:26:00 CST 2019, time=2019-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509694, encodeId=37f8150969477, content=<a href='/topic/show?id=c96f866535c' target=_blank style='color:#2F92EE;'>#良性前列腺增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86653, encryptionId=c96f866535c, topicName=良性前列腺增生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42f10130242, createdName=刘阔, createdTime=Sun Mar 17 03:26:00 CST 2019, time=2019-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602132, encodeId=947f1602132c5, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Sun Mar 17 03:26:00 CST 2019, time=2019-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046775, encodeId=92b11046e75c4, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Mar 15 15:26:00 CST 2019, time=2019-03-15, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1877131, encodeId=e67d18e71315f, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sat Sep 07 21:26:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791570, encodeId=4e3d1e91570fb, content=<a href='/topic/show?id=b77f14e4541' target=_blank style='color:#2F92EE;'>#Prostate Ca#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14745, encryptionId=b77f14e4541, topicName=Prostate Ca)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Thu Nov 21 23:26:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364467, encodeId=9791136446e71, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Sun Mar 17 03:26:00 CST 2019, time=2019-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509694, encodeId=37f8150969477, content=<a href='/topic/show?id=c96f866535c' target=_blank style='color:#2F92EE;'>#良性前列腺增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86653, encryptionId=c96f866535c, topicName=良性前列腺增生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42f10130242, createdName=刘阔, createdTime=Sun Mar 17 03:26:00 CST 2019, time=2019-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602132, encodeId=947f1602132c5, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Sun Mar 17 03:26:00 CST 2019, time=2019-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046775, encodeId=92b11046e75c4, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Mar 15 15:26:00 CST 2019, time=2019-03-15, status=1, ipAttribution=)]
    2019-03-17 sunylz
  6. [GetPortalCommentsPageByObjectIdResponse(id=1877131, encodeId=e67d18e71315f, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sat Sep 07 21:26:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791570, encodeId=4e3d1e91570fb, content=<a href='/topic/show?id=b77f14e4541' target=_blank style='color:#2F92EE;'>#Prostate Ca#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14745, encryptionId=b77f14e4541, topicName=Prostate Ca)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Thu Nov 21 23:26:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364467, encodeId=9791136446e71, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Sun Mar 17 03:26:00 CST 2019, time=2019-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509694, encodeId=37f8150969477, content=<a href='/topic/show?id=c96f866535c' target=_blank style='color:#2F92EE;'>#良性前列腺增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86653, encryptionId=c96f866535c, topicName=良性前列腺增生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42f10130242, createdName=刘阔, createdTime=Sun Mar 17 03:26:00 CST 2019, time=2019-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602132, encodeId=947f1602132c5, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Sun Mar 17 03:26:00 CST 2019, time=2019-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046775, encodeId=92b11046e75c4, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Mar 15 15:26:00 CST 2019, time=2019-03-15, status=1, ipAttribution=)]
    2019-03-15 CHANGE

    疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的

    0

相关资讯

Nat Commun:前列腺基底细胞分化过程中,miR-205宿主基因的LEADeR角色研究

最近,有研究人员指出,miR-205的大部分功能还没有鉴定,且它的宿主基因MIR205HG的相关功能完全未知。研究发现,只有低表达的可变剪接MIR205HG转录本作为实际上的pri-miRNAs,该过程涉及了Drosha来消除不利的剪接,并且能够直接调节调控miR-205消除。明显的是,MIR205HG特异性加工过的转录本实际上是作为长非编码RNA来起作用的,并且具有通过对干扰素途径进行调节来调控

盘点:近期前列腺疾病进展盘点

前列腺是男性生殖器附属腺中最大的实质性器官。由前列腺组织和肌组织构成。前列腺癌是指发生在前列腺的上皮性恶性肿瘤。2004年WHO《泌尿系统及男性生殖器官肿瘤病理学和遗传学》中前列腺癌病理类型上包括腺癌(腺泡腺癌)、导管腺癌、尿路上皮癌、鳞状细胞癌、腺鳞癌。其中前列腺腺癌占95%以上,因此,通常我们所说的前列腺癌就是指前列腺腺癌。梅斯医学小编整理了近期前列腺疾病的研究进展,与大家一起分享学习!【

Radiology:MRI放射组学机器学习与ADC值在评价前列腺病变的价值

本研究旨在比较术前MRI阅片中比较双参数非对比放射组学机器学习(RML)平均表观扩散系数和放射科医生评价前列腺病变特点的差异。

Sci Rep:环境毒物能够诱导前列腺病理的表观遗传继代遗传

前列腺疾病包括了前列腺癌,是第二大最为常见的男性肿瘤,并且联想前列腺增生(BPH)影响着大约50%的男性。前列腺疾病的发生率在增加,并且增加的一些原因中可能包括了祖先对环境毒物的接触以及表观遗传的继代遗传机制。最近,有研究人员确定了怀孕的雌性老鼠接触乙烯菌核利对前列腺疾病表观继代遗传的影响,并鉴定了相关的分子表观遗传机制。研究发现,接触乙烯菌核利的F3雄性小鼠在12个月大时,前列腺组织病理和异常与

Brit J Cancer:积极监控局部前列腺癌患者的饮食质量和格林森等级恶化研究

高质量的饮食能够维持较好的代谢和抗炎症状态并且不利于肿瘤的恶化。最近,有研究人员在积极监督局部前列腺癌患者中前瞻性的调查了饮食质量与格林森等级恶化之间的关系;积极监督是一种疾病控制和推迟干预的临床治疗策略。研究包括了新诊断格林森得分在6或者7的前列腺癌男性;这些患者在基线时间点(n=411)和跟踪调查的首6个月(n=263)完成了一份食物频率调查问卷(FFQ)。研究人员还利用Cox比例风险模型来评

Prostate Cancer P D:PCA3和TMPRSS2:ERG 泌尿生物标记在预测活检结果中的表现分析

对于那些前列腺癌积极监控的男性来讲,生物标记可能改善再分类预测到更高的等级或者体积癌症。最近,有研究人员调查了泌尿标记PCA3和TMPRSS2:ERG(T2:ERG)与基于活检的再分类之间的相关性。研究人员在基线时间点、6、12和24个月时收集了患者的尿液,并定量了PCA3和T2:ERG的水平。在分类定义为格林森得分的增加或者癌症活检核心比例不小于34%。调整了常见的临床变量后,研究人员还评估了生

Baidu
map
Baidu
map
Baidu
map